Skip to main content
BSX
NYSE Industrial Applications And Services

Boston Scientific Prices €4.25B Six-Tranche Euro Notes to Fund Penumbra Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$43
Mkt Cap
$62.313B
52W Low
$39.57
52W High
$101.91
52W Position info
8.7% above low
Off High info
58% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $39.57 (8.7% above the low).

Summary

Boston Scientific priced €4.25 billion of guaranteed senior notes in six euro tranches to fund the cash consideration for its ~$14.5 billion Penumbra acquisition, with settlement December 1, 2026.


Key Events · Financing and Capital Events · BSX

  • €4.25B Six-Tranche Euro Notes Priced

    The six tranches comprise €500M 2-yr FRN at EURIBOR+63bp, €500M 2028 at 3.875%, €750M 2030 at 4.125%, €750M 2034 at 4.500%, €1.0B 2038 at 4.750% and €750M 2046 at 5.125%, all guaranteed by Boston Scientific.

  • Proceeds Fund Penumbra Cash Consideration

    Net proceeds, together with a concurrent USD notes offering, short-term borrowings and cash on hand, will finance the cash consideration for the ~$14.5 billion Penumbra Acquisition and related fees.

  • Deal-Failure Redemption at 101%

    The four fixed-rate tranches must be redeemed at 101% of principal plus accrued interest if the Penumbra Acquisition is not completed by the Special Mandatory Redemption End Date or Boston Scientific abandons it.

  • Settlement December 1, 2026

    Trade date is November 19, 2026, with T+8 settlement on December 1, 2026; the notes list on Euronext Dublin's Global Exchange Market and clear through Clearstream and Euroclear.


Analysis · BSX · Industrial Applications And Services

The Dutch finance arm of Boston Scientific has locked in €4.25 billion of senior notes across six tranches, ranging from a 2-year floater at EURIBOR plus 63bp to a 20-year fixed at 5.125%. Because the proceeds fund the cash portion of the ~$14.5 billion Penumbra acquisition, this is debt-funded M&A rather than dilution: existing shareholders are not diluted, but leverage rises, and the four fixed-rate tranches carry a 101% special mandatory redemption if the deal does not close by the stated end date. Investment-grade ratings (A3/A-/A-) kept coupons moderate, with the 12-year tranche the largest single piece at €1.0 billion.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BSX was trading at $43.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $62.3B. The 52-week trading range was $39.57 to $101.91. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 19, 2026, 8:38 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $43.36
Real-time Price: $43.00 info
Change: -$0.360 (-0.83%) info
Market Cap: $62.313B info
BSX
Nov 19, 2026, 6:03 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $43.51
Real-time Price: $43.00 info
Change: -$0.510 (-1%) info
Market Cap: $62.313B info
BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $43.00 info
Change: -$1.16 (-3%) info
Market Cap: $62.313B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $43.00 info
Change: -$1.24 (-3%) info
Market Cap: $62.313B info
BSX
Oct 29, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.15
Real-time Price: $43.00 info
Change: +$0.8499 (+2%) info
Market Cap: $62.313B info